This drug class, often known as GLP-1 agonists, features semaglutide—authorized as Ozempic for style 2 diabetes and Wegovy for obesity—and tirzepatide—authorized as Mounjaro for diabetes and Zepbound for https://amaancyln114846.liberty-blog.com/profile